Company intelligence / Profile preview

Ultrahuman

Bangalore/Bengaluru, Karnataka, Indiaultrahuman.com ↗

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Ultrahuman has demonstrated strong commercial traction with its wearable devices validated for clinical-grade accuracy in measuring metabolic score, insulin sensitivity, inflammation markers, sleep quality metrics. The company reported ₹620 crore (~$75M) revenue in FY2024 and continues to expand internationally after raising $35M in Series B funding in early 2024.

Therapeutic areas: OtherMetabolic DisordersNeurology
Modalities: DeviceNon-pharmacological therapy (wellness/behavioral modification)Digital health platformBiosensor technology
Industry: Physiological Monitoring

Partnerships

UAE Team EmiratesTeam ADQOther high-performance sports teams using the products as partners/testimonials[1]

Beyond the preview

Go deeper on Ultrahuman.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultrahuman.

Explore the full profile